Wandercraft Personal Exoskeleton Achieves 100% Success Rate for Key Usability Tasks in New Study
New data show high usability, safety, and user confidence among individuals with high-level spinal cord injury
New York, NY (May 14, 2025) – Wandercraft, a global leader in robotic mobility solutions, released new clinical findings from a study, Human Factors Validation Testing of the Wandercraft Personal Exoskeleton, that evaluated usability and safety in individuals with complete or incomplete SCI at or above T6 (sixth thoracic vertebrae).
After only five training sessions, participants demonstrated a median success rate of 100% in executing critical mobility tasks, including setup, control, navigation, and safe emergency extraction procedures in simulated home and community environments. Participants successfully navigated realistic indoor and outdoor simulations, including uneven surfaces and tight spaces.
“This is a major step toward realizing our vision of restoring upright mobility in the real world,” said Joshua Breighner, Value & Access Manager of Wandercraft and study presenter. “For the first time, we’ve shown that individuals with high-level SCI can learn to use a self-balancing, powered exoskeleton independently and safely in the context of daily life. More than just a device, we are building a new category of mobility freedom.”
Study Highlights:
- Exceptional success rate: 100% median performance across 16 critical tasks (80% for emergency extraction)
- High user confidence: Average >93%
- Outstanding companion usability: Achieved 5.0/5.0 rating in remote control usage and supervision tasks
- Rapid training time: Only five sessions (~1–2 hours each)
- Quick donning and transfer times: Transfer: 1.2 ± 0.9 mins, Donning: 9.9 ± 5.9 mins
These findings represent a significant milestone in Wandercraft’s mission to bring real-world, upright mobility to wheelchair users. With clinical trials underway, the Personal Exoskeleton is advancing toward commercialization as early as next year, with plans to start working with payors to enable even greater access to this technology.
About Wandercraft
Wandercraft is on a mission to give everyone the opportunity to stand up and walk again. Known for the first-of-its-kind Personal Exoskeleton, Wandercraft is building the next generation of solutions to restore walking ability at home and in rehabilitation, including the Atalante X – a revolutionary tool in use within inpatient and outpatient rehab centers worldwide.
By blending advanced robotics with a deeply human purpose, Wandercraft aims to provide new options for movement and soon transform the way wheelchair users experience walking mobility in their everyday lives. Committed to innovation and accessibility, Wandercraft welcomes collaboration with rehabilitation centers, healthcare professionals, and the broader community of wheelchair users to expand opportunities in modern mobility. For more information, visit www.wandercraft.eu.
Media Contact
Lilly Kofler
Global Head of Marketing & Communications
lilly.kofler@wandercraft.health
